文献速递肾小球疾病慢性肾脏病

年龄校正后的全球性肾小球硬化对肾病综合征患者的临床意义

Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment.
PubMed 文献 · Kidney Int · 2017-12-19

本研究基于NEPTUNE、中国DiKiP和东南明尼苏达队列,纳入425例常表现为肾病综合征的肾小球疾病患者,以正常血压活体供肾者的年龄相关95百分位阈值为标准,将患者分为无全球性肾小球硬化、年龄正常范围和超出年龄范围三组。结果显示,仅超出年龄预期的全球性肾小球硬化与终末期肾病或肾小球滤过率下降40%的风险显著增加相关,且经多因素调整后仍显著。

要点

  • 全球性肾小球硬化在正常衰老和肾脏病中均可出现,需年龄校正评估。
  • 仅超出年龄预期的全球性肾小球硬化与肾病进展风险增加独立相关。
  • 年龄正常范围内的全球性肾小球硬化进展风险与无硬化者相似。

核心结论

  • 在常表现为肾病综合征的肾小球疾病患者中,只有超出年龄预期的全球性肾小球硬化才具有临床重要性。

研究设计与样本

  • 基于NEPTUNE、中国DiKiP和东南明尼苏达三个队列,纳入425例局灶节段性肾小球硬化、膜性肾病或微小病变患者。
  • 以正常血压活体供肾者的年龄相关95百分位阈值定义全球性肾小球硬化分组。

主要发现

  • 425例中,无全球性肾小球硬化170例,年龄正常范围107例,超出年龄范围148例。
  • 与无全球性肾小球硬化相比,年龄正常范围者肾脏病进展风险相似,而超出年龄范围者风险显著更高。
  • 超出年龄范围者的风险增加在调整间质纤维化、动脉硬化、年龄、高血压、糖尿病、体重指数、肾小球疾病类型、肾小球滤过率和蛋白尿后仍显著。

临床怎么用

  • 评估肾小球疾病患者全球性肾小球硬化时,应参照年龄校正的阈值判断其临床意义。
  • 超出年龄预期的全球性肾小球硬化提示肾脏病进展风险增高,需加强监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Globally sclerotic glomeruli (GSG) occur with both normal aging and kidney disease. However, it is unknown whether any GSG or only GSG exceeding that expected for age is clinically important. To evaluate this, we identified patients with a glomerulopathy that often presents with nephrotic syndrome (focal segmental glomerulosclerosis, membranous nephropathy, or minimal change disease) in the setting of the Nephrotic Syndrome Study Network (NEPTUNE), China-Digital Kidney Pathology (DiKiP), and the Southeast Minnesota cohorts. Age-based thresholds (95th percentile) for GSG based on normotensive living kidney donors were used to classify each patient into one of three groups; no GSG, GSG normal for age, or GSG abnormal for age. The risk of end-stage renal disease or a 40% decline in glomerular filtration rate during follow-up was then compared between groups. Among the 425 patients studied, 170 had no GSG, 107 had GSG normal for age, and 148 had GSG abnormal for age. Compared to those with no GSG, the risk of kidney disease progression with GSG normal for age was similar but was significantly higher with GSG abnormal for age. This increased risk with GSG abnormal for age remained significant after adjustment for interstitial fibrosis, arteriosclerosis, age, hypertension, diabetes, body mass index, glomerulopathy type, glomerular filtration rate, and proteinuria. Thus, in patients with glomerulopathy that often presents with nephrotic syndrome, global glomerulosclerosis is clinically important only if it exceeds that expected for age.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Hommos MS, Zeng C, Liu Z, et al. Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment. Kidney Int. 2017. PMID: 29273332. doi:10.1016/j.kint.2017.09.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。